PALI
Income statement / Annual
Last year (2025), Palisade Bio Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Palisade Bio Inc's net income was -$16.78 M.
See Palisade Bio Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$0.00 |
$0.00 |
$250.00 K |
$0.00 |
$0.00 |
$0.00 |
$15.39 K |
$260.00 K |
$260.00 K |
$16.25 K |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$146.00 K
|
$0.00
|
-$990.00 K
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$250.00 K
|
$0.00
|
$0.00
|
-$146.00 K
|
$15.39 K
|
$1.25 M
|
$260.00 K
|
$16.25 K
|
| Gross Profit Ratio |
0
|
0
|
1
|
0
|
0
|
0
|
1
|
4.81
|
1
|
1
|
| Research and Development Expenses |
$10.19 M
|
$9.06 M
|
$6.89 M
|
$6.55 M
|
$2.43 M
|
$3.10 M
|
$4.06 M
|
$3.96 M
|
$8.00 M
|
$12.84 M
|
| General & Administrative Expenses |
$7.86 M
|
$5.80 M
|
$6.20 M
|
$8.76 M
|
$9.31 M
|
$0.00
|
$7.27 M
|
$3.57 M
|
$5.47 M
|
$7.50 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$2.83 M
|
$807.46 K
|
-$289.00 K
|
-$496.00 K
|
| Selling, General & Administrative Expenses |
$7.86 M
|
$5.80 M
|
$6.20 M
|
$8.76 M
|
$9.31 M
|
$6.05 M
|
$4.44 M
|
$4.37 M
|
$5.18 M
|
$7.00 M
|
| Other Expenses |
$0.00
|
$0.00
|
$225.00 K
|
$410.00 K
|
$30.12 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$18.06 M
|
$14.86 M
|
$13.32 M
|
$15.72 M
|
$41.85 M
|
$9.15 M
|
$8.65 M
|
$8.52 M
|
$13.57 M
|
$20.65 M
|
| Cost And Expenses |
$18.06 M
|
$14.86 M
|
$13.32 M
|
$15.72 M
|
$41.85 M
|
$9.30 M
|
$8.65 M
|
$8.52 M
|
$13.48 M
|
$20.18 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$13.00 K
|
$0.00
|
$0.00
|
$67.73 K
|
$78.78 K
|
$70.27 K
|
$58.84 K
|
| Interest Expense |
$10.00 K
|
$12.00 K
|
$15.00 K
|
$13.00 K
|
$2.40 M
|
$235.00 K
|
$8.92 K
|
$7.70 K
|
$159.07 K
|
$1.14 M
|
| Depreciation & Amortization |
$3.00 K
|
$3.00 K
|
$4.00 K
|
$3.00 K
|
$2.00 K
|
$146.00 K
|
$143.86 K
|
$185.80 K
|
$289.21 K
|
$337.51 K
|
| EBITDA |
-$16.77 M |
-$14.42 M |
-$12.28 M |
-$14.24 M |
-$24.22 M |
-$9.94 M |
-$8.20 M |
-$4.73 M |
-$15.22 M |
-$19.60 M |
| EBITDA Ratio |
0
|
0
|
-49.12
|
0
|
0
|
0
|
-532.61
|
-18.2
|
-58.53
|
-1206.2
|
| Operating Income Ratio |
0
|
0
|
-52.28
|
0
|
0
|
0
|
-560.74
|
-31.77
|
-50.83
|
-1241.35
|
| Total Other Income/Expenses Net |
$1.28 M
|
$421.00 K
|
$770.00 K
|
$1.46 M
|
$15.24 M
|
-$1.03 M
|
$280.04 K
|
$3.34 M
|
-$2.45 M
|
-$908.00 K
|
| Income Before Tax |
-$16.78 M
|
-$14.44 M
|
-$12.30 M
|
-$14.26 M
|
-$26.62 M
|
-$10.32 M
|
-$8.35 M
|
-$4.93 M
|
-$15.67 M
|
-$21.08 M
|
| Income Before Tax Ratio |
0
|
0
|
-49.2
|
0
|
0
|
0
|
-542.55
|
-18.94
|
-60.25
|
-1297.24
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$16.78 M
|
-$14.44 M
|
-$12.30 M
|
-$14.26 M
|
-$26.62 M
|
-$10.32 M
|
-$8.35 M
|
-$4.93 M
|
-$15.67 M
|
-$21.08 M
|
| Net Income Ratio |
0
|
0
|
-49.2
|
0
|
0
|
0
|
-542.55
|
-18.94
|
-60.25
|
-1297.24
|
| EPS |
-0.3 |
-10.19 |
-27.01 |
-16.53 |
-2144.25 |
-186 |
-14.78 |
-18.02 |
-71.59 |
-126.11 |
| EPS Diluted |
-0.3 |
-10.19 |
-27.01 |
-16.53 |
-2546.1 |
-186 |
-35.18 |
-18.02 |
-71.34 |
-126.11 |
| Weighted Average Shares Out |
$55.67 M
|
$1.42 M
|
$456.01 K
|
$880.10 K
|
$12.41 K
|
$832.31 K
|
$122.41 K
|
$273.24 K
|
$218.84 K
|
$8.35 K
|
| Weighted Average Shares Out Diluted |
$55.67 M
|
$1.42 M
|
$456.01 K
|
$880.31 K
|
$12.46 K
|
$237.39 K
|
$237.39 K
|
$273.24 K
|
$219.60 K
|
$8.35 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
